COMMUNIQUÉS West-GlobeNewswire

Spectral to Attend the 37th Annual J.P. Morgan Healthcare Conference

19/12/2018 - 14:00

TORONTO, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) , a Phase III company developing the first treatment for patients with endotoxemic septic shock guided by a [...]

Nemaura to Host Investor Webinar on December 21 to Provide Update on Recent Developments

19/12/2018 - 14:00

LOUGHBOROUGH, England - Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]

Krystal Biotech Completes Dosing in the GEM-Phase 2 Study in Pediatric Patients for the Treatment of Dystrophic Epidermolysis Bullosa

19/12/2018 - 14:00

Top line results from GEM-Phase 2 study expected in H1 2019 PITTSBURGH, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company developing topical and intradermal "off [...]

AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference

19/12/2018 - 14:00

WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, president and chief executive officer, will present at the 37 th Annual J.P. Morgan [...]

Johnson & Johnson's Biosense Webster’s MaryAnn Edzards Joins BioSig

19/12/2018 - 14:00

Former New Technology Education Manager to Assist with First Installations Santa Monica, CA, Dec. 19, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]

resTORbio Appoints William Marshall, M.D., as Vice President of Medical Sciences

19/12/2018 - 14:00

BOSTON, Dec. 19, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq:TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]

RTI Donor Services and Versiti Celebrate the Gift of Tissue Donation with Donate Life Float in 2019 Rose Parade®

19/12/2018 - 14:00

RTI Donor Services sponsors tissue recipient as walker on float MILWAUKEE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- RTI Donor Services (RTIDS), a nonprofit organization dedicated to providing responsible stewardship of the [...]

Allogene Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference

19/12/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for [...]

Immunomedics To Present at the 37th Annual J.P. Morgan Healthcare Conference

19/12/2018 - 14:00

MORRIS PLAINS, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates, today announced [...]

Avenue Therapeutics Announces Dosing of First Patient in Second Pivotal Phase 3 Clinical Trial of Intravenous Tramadol for the Management of Postoperative Pain

19/12/2018 - 14:00

Topline data readout expected in mid-2019 NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and [...]

CardioDx Presents Comparative Effectiveness Claims Analysis Highlighting the Clinical Value of the Corus® CAD Precision Medicine Blood Test in Elderly Patients at the Gerontological Society of America 2018 Annual Meeting

19/12/2018 - 14:00

Corus CAD Blood Test Was Associated With Decreased Downstream CAD-Related Healthcare Utilization in the Real-World Study of Elderly Patients Evaluated for Suspected Coronary Artery Disease REDWOOD CITY, Calif., Dec. 19 [...]

Avalon GloboCare to Ring the Nasdaq Stock Market Closing Bell on January 7, 2019 at 4:00 PM Eastern

19/12/2018 - 14:00

FREEHOLD, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of cell-based technologies and therapeutics, today announced that it will ring The Nasdaq Stock Market [...]

AzurRx BioPharma Announces Initiation of Phase II OPTION Clinical Trial of MS1819-SD in Cystic Fibrosis Patients

19/12/2018 - 14:00

First site initiated at the Cystic Fibrosis Institute Initial top line data expected in 2019 NEW YORK, Dec. 19, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company [...]

KemPharm Provides Corporate Update on Partnering Process for ADHD Prodrug Portfolio

19/12/2018 - 13:30

CELEBRATION, Fla., Dec. 19, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, today provided a corporate update [...]

Strongbridge Biopharma plc Announces Closing of Transaction with Novo Nordisk to Transfer the Rights to MACRILEN™ (macimorelin) in the United States and Canada

19/12/2018 - 13:30

Strongbridge Used Portion of $145 Million Upfront Cash Payment from Novo Nordisk to Fully Repay Outstanding Debt DUBLIN, Ireland and TREVOSE, Pa., Dec. 19, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: [...]

Radient Technologies Inc. Files Provisional Applications for Innovating Cannabinoid-Infused Food & Beverage Manufacturing Processes

19/12/2018 - 13:30

EDMONTON, Alberta, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) is pleased to announce that it has now filed an additional 9 provisional [...]

Mesoblast Makes Executive Appointment to Drive Product Commercialization

19/12/2018 - 13:22

NEW YORK and MELBOURNE, Australia, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB) today announced that it has appointed Eric Strati, PhD, to the new position of Senior Vice President, [...]

Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader

19/12/2018 - 13:19

Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres; Aleafia patients to access Emblem’s differentiated, high margin derivative products [...]

Loop Industries and thyssenkrupp Sign Global Alliance Agreement to Transform the Future of Sustainable Pet Plastic Manufacturing

19/12/2018 - 13:15

Global Alliance Agreement aims to combine Loop Industries’ depolymerization technology with thyssenkrupp Industrial Solutions’ PET Melt-To-Resin® technology Integration of technologies is intended to provide rapidly [...]